Prospective, multi-center, open-label, randomized, omega-3-acid ethyl ester-controlled trial to assess the impact of the pemafibrate on liver function in hypertriglyceridemia patients with non-alcoholic fatty liver disease (Portrait study)
JOURNAL OF HEPATOLOGY（2023）
关键词
hypertriglyceridemia patients,liver function,liver disease,fatty,multi-center,open-label,ester-controlled,non-alcoholic
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要